Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL266277

CCc1ccc(C(F)(F)F)cc1.N

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.52
IDO1 P14902 4/20 0.50
MAOB P27338 1/20 0.45
ALDH1A1 P00352 3/20 0.44
PYCR1 P32322 1/20 0.44
KDM4E B2RXH2 1/20 0.44
PLK1 P53350 1/20 0.43
KIF11 P52732 1/20 0.42
KMT2A Q03164 1/20 0.42
MIF P14174 1/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL91061 0.97 TAAR1 (0.54) TAAR1IDO1MAOBALDH1A1PYCR1
SCHEMBL31277159 0.91 SRD5A2 (0.50) TAAR1IDO1MAOBALDH1A1PYCR1
SCHEMBL1687449 0.91 MAOB (0.57) TAAR1IDO1MAOBKIF11
SCHEMBL29124537 0.89 TAAR1 (0.47) TAAR1IDO1MAOBALDH1A1PYCR1
SCHEMBL12806599 0.85 MEN1 (0.48) TAAR1IDO1MAOBKMT2AMAPT
SCHEMBL8990814 0.85 MAOB (0.61) TAAR1MAOBKIF11MIF
SCHEMBL12603780 0.85 PTGS1 (0.52) TAAR1MAOB
SCHEMBL19010903 0.82 TP53 (0.47) TAAR1IDO1MAOBALDH1A1KDM4E
Ammonia Solution, Strong SCHEMBL6193177 0.81 TAAR1 (0.59) TAAR1IDO1MAOBPLK1MIF
SCHEMBL18164548 0.80 MAOB (0.70) IDO1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8431378-B2 Aminotransferase, gene encoding the same, and methods of using them KANEKA CORPORATION (JP) 2013-04-30 US disclosed
US-20120164724-A1 NOVEL AMINOTRANSFERASE, GENE ENCODING THE SAME, AND METHODS OF USING THEM KANEKA CORPORATION (JP) 2012-06-28 US disclosed
US-8133705-B2 Aminotransferase, gene encoding the same, and method of using them KANEKA CORPORATION (JP) 2012-03-13 US disclosed
US-20100285544-A1 Novel aminotransferase, gene encoding the same, and method of using them KANEKA CORPORATION (JP) 2010-11-11 US disclosed
EP-1889907-B1 NOVEL AMINO GROUP TRANSFERASE, GENE ENCODING THE SAME AND METHOD OF USING THE SAME KANEKA CORP (JP) 2009-09-02 EP disclosed
EP-1045025-B1 (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE KANEKA CORP (JP) 2008-10-22 EP disclosed
EP-1889907-A1 NOVEL AMINO GROUP TRANSFERASE, GENE ENCODING THE SAME AND METHOD OF USING THE SAME Kaneka Corporation (JP) 2008-02-20 EP disclosed
US-6346402-B1 ACTS ON OPTICALLY ACTIVE (S)-ALPHA-PHENETHYLAMINE AND PYRUVIC ACID TO FORM ACETOPHENONE AND ALANINE; FOR PRODUCING CHEMICAL INTERMEDIATES OF DRUGS AND AGRICULTURAL CHEMICALS KANEKA CORPORATION (JP) 2002-02-12 US disclosed
EP-1045025-A1 (S)-alpha-PHENETHYLAMINE : PYRUVATE TRANSAMINASE KANEKA CORPORATION (JP) 2000-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100285544-A1 Novel aminotransferase, gene encoding the same, and method of using them BCAT1, AGXT, ALDH7A1 TAAR1 1322/4885IDO1 417/4885MAOB 1260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.